Byrne Upper GI Surgery Limited 13966887 false 2023-04-01 2024-03-31 2024-03-31 The principal activity of the company is general medical services. Digita Accounts Production Advanced 6.30.9574.0 true true 13966887 2023-04-01 2024-03-31 13966887 2024-03-31 13966887 core:RetainedEarningsAccumulatedLosses 2024-03-31 13966887 core:ShareCapital 2024-03-31 13966887 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 13966887 core:Non-currentFinancialInstruments core:AfterOneYear 2024-03-31 13966887 bus:SmallEntities 2023-04-01 2024-03-31 13966887 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 13966887 bus:FullAccounts 2023-04-01 2024-03-31 13966887 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 13966887 bus:RegisteredOffice 2023-04-01 2024-03-31 13966887 bus:Director1 2023-04-01 2024-03-31 13966887 bus:Director2 2023-04-01 2024-03-31 13966887 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 13966887 core:MotorVehicles 2023-04-01 2024-03-31 13966887 core:PlantMachinery 2023-04-01 2024-03-31 13966887 countries:EnglandWales 2023-04-01 2024-03-31 13966887 2023-03-31 13966887 2022-03-09 2023-03-31 13966887 2023-03-31 13966887 core:RetainedEarningsAccumulatedLosses 2023-03-31 13966887 core:ShareCapital 2023-03-31 13966887 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 13966887 core:Non-currentFinancialInstruments core:AfterOneYear 2023-03-31 iso4217:GBP xbrli:pure

Registration number: 13966887

Byrne Upper GI Surgery Limited

Annual Report and Unaudited Filleted Abridged Financial Statements

for the Year Ended 31 March 2024

 

Byrne Upper GI Surgery Limited

Contents

Abridged Balance Sheet

1

Notes to the Unaudited Abridged Financial Statements

2 to 3

 

Byrne Upper GI Surgery Limited

(Registration number: 13966887)
Abridged Balance Sheet as at 31 March 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

4

9,774

11,158

Current assets

 

Debtors

2,446

2,706

Cash at bank and in hand

 

23,240

4,000

 

25,686

6,706

Creditors: Amounts falling due within one year

(25,568)

(6,279)

Net current assets

 

118

427

Total assets less current liabilities

 

9,892

11,585

Creditors: Amounts falling due after more than one year

(4,145)

(6,632)

Net assets

 

5,747

4,953

Capital and reserves

 

Called up share capital

100

100

Profit and loss account

5,647

4,853

Total equity

 

5,747

4,953

For the financial year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the Board on 6 October 2024 and signed on its behalf by:
 

Dr B E Byrne

Director

Mrs L O Byrne

Director

 

Byrne Upper GI Surgery Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Calyx House
South Road
Taunton
Somerset
TA1 3DU
Somerset

These financial statements were authorised for issue by the Board on 6 October 2024.

2

Accounting policies

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

 

Byrne Upper GI Surgery Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2024

Asset class

Depreciation method and rate

Motor vehicles

20% Straight Line

Plant & Machinery

20% Reducing Balance

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee.

Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight-line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the balance sheet as a finance lease obligation.

Lease payments are apportioned between finance costs in the profit and loss account and reduction of the lease obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2023 - 2).

4

Tangible assets

Total
£

Cost or valuation

At 1 April 2023

13,948

Additions

1,757

At 31 March 2024

15,705

Depreciation

At 1 April 2023

2,790

Charge for the year

3,141

At 31 March 2024

5,931

Carrying amount

At 31 March 2024

9,774

At 31 March 2023

11,158